About this event

  • Date and time Mon 13 Jul 2020 from 9:00am to 2:30pm
  • Location Royal Society of Medicine
  • Organised by Medicine and Me, Action Against AMD

This event has been postponed and is now planned to take place as a webinar on Thursday 22 April 2021. Find out more and book your place here

Jointly organised with Action Against Age-related Macular Degeneration (AAAMD) this meeting will hear from people living age-related macular degeneration (AMD) condition and from experts who work with people with AMD. 

AMD is one of the leading causes of blindness in the world. Around 10 million people have late-stage AMD globally. In the UK alone there are more than 685,000 people with significant sight loss as a consequence of late-stage AMD and with an ageing world population, AMD cases are expected to double by 2040. 

We will be joined by a multidisciplinary faculty of speakers, including people with AMD, their carers and relatives, expert clinicians and researchers to review and discuss current and future approaches to diagnosis and treatment of AMD in the light of an increased understanding of the biology, genetics and epidemiology.

What will you learn?

By attending this meeting, you will have the opportunity to:

  • Understand the "status quo" about AMD biology: one or many diseases?
  • Know about today’s treatments, their benefits and shortcomings
  • Know about the potential of addressing AMD at its early or intermediate stages
  • Understand the potential through “big data” of early recognition of those at risk from developing AMD
  • Understand the need for a new paradigm to address the challenge of AMD in an ageing population

About Medicine and Me

Medicine and Me meetings aim to provide an outline of current best practice and future updates of important conditions and to give direct voice to patients and their carers and enable them to discuss their concerns and reflections on the impact of diagnosis, investigation and management.

Physicians and surgeons and indeed all healthcare professionals continue to learn from and be inspired to greater efforts to improve care by hearing directly from patients.

Join in the conversation online
Follow us on Twitter: @RoySocMed


View the programme

Registration, tea and coffee

Dr Fiona Moss, Dean, Royal Society of Medicine


Dr Wen Hwa Lee, Chief Executive, Action on Age Related Macular Degeneration

Age related macular degeneration: Three personal perspectives

To be confirmed

Age related macular degeneration: Who gets it, why and what can we do today?

Ms Dawn Sims, Consultant Ophthalmologist, Moorfields Eye Hospital NHS Foundation Trust

Question and answers
Unmet need: Focusing on early and intermediate age related macular degeneration

Dr Wen Hwa Lee

Question and answers
Tea and coffee break
Big data and age related macular degeneration

Dr Pearse Keane,  Associate Professor, University College London Instiute of Ophthalmology, Faculty of Brain Science

Question and answers
Moving towards good eye health: How near is the future? Ethics, costs and practicalities

Panel discussion facilitated by Mr Beng Ong, Specialist Registrar, Western Eye Hospital

Panel: Professor Alastair Denniston, Honorary Professor, Institute of inflammation and aging, Univeristy of Birmingham and Consultant Ophthalmologist, University Hospitals Birmingham and Natalie Banner, Policy Adviser, Wellcome Trust

Close of meeting


Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom

Man searching computer

Join the RSM and get free access to digital learning resources

The RSM has an extensive digital learning and online e-resources platform. As a member you'll enjoy free access to a wealth of online  resources, including 5,000 subscription and open access e-journals, 2,000 e-books and 5 key medical databases, to support your clinical decision-making and research.

Become a member